PIK-ORL: A phase II, multicenter trial aiming to evaluate...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

PIK-ORL: A phase II, multicenter trial aiming to evaluate BKM120 in monotherapy in patients (pts) with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC) after failure of platin and cetuximab or anti-EGFR-based therapy

Fayette, J., Digue, L., Ferlay, C., Treilleux, I., Garin, G., Wang, Q., Hebert, C., Even, C., Cupissol, D., Couchon-Thaunat, S., Jaouen, L., Guyennon, A., Le Tourneau, C., Lefebvre, G., Mailliez, A.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw376.11
Date:
October, 2016
File:
PDF, 43 KB
english, 2016
Conversion to is in progress
Conversion to is failed